BACKGROUND: Studies have shown high levels of distress and mental disorder among people living in refugee camps, yet none has confirmed diagnosis through clinical reappraisal.
Médecins Sans Frontières (MSF) is a humanitarian organisation which provides emergency medical aid in challenging settings; field staff often diagnose and treat patients using limited resources and without the expertise of specialists.
Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa.
BACKGROUND: The World Health Organization recommends African children receive two doses of measles containing vaccine (MCV) through routine programs or supplemental immunization activities (SIA).
BACKGROUND: Early recognition of bacterial infections is crucial for their proper management, but is particularly difficult in children with severe acute malnutrition (SAM).
Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study.
SETTING: Armenia, a country with a high prevalence of drug-resistant tuberculosis (DR-TB).
OBJECTIVE: To identify factors related to default from DR-TB treatment in Yerevan.
INTRODUCTION: During January 2010, a 7.0 magnitude earthquake struck Haiti, resulting in death and destruction for hundreds of thousands of people.
Reaching hard-to-reach individuals: Nonselective versus targeted outbreak response vaccination for measles.
Current mass vaccination campaigns in measles outbreak response are nonselective with respect to the immune status of individuals.
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
BACKGROUND: A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity.
Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya.
Between 2000 and 2010, Médecins Sans Frontières diagnosed and treated 4,831 patients with visceral leishmaniasis (VL) in the Pokot region straddling the border between Uganda and Kenya.